Maryellen Bishop
Atlanta, GANPI 1992147961
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $229,765 of the $291,256 with a category attached, or 78.9%. AbbVie accounts for 99.9% of it on its own, with 3 other manufacturers making up the rest.
Across 423 payments — averaging $688.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$291K
- Galderma Laboratories, L.p.$224
- Revance Therapeutics, Inc.$82
- Mentor Worldwide LLC$44
What the payments were for
- Consulting fees$18,5146%
- Speaking & faculty fees$229,76579%
- Travel & lodging$33,88312%
- Food & beverage$9,0943%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 412 | $290,905 |
| Galderma Laboratories, L.p. | 9 | $224 |
| Revance Therapeutics, Inc. | 1 | $82 |
| Mentor Worldwide LLC | 1 | $44 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.